ON-DEMAND WEBINAR

Innovation and Digital Revolution in Biopharma: The Path Forward

Overview

In this webinar our visionary panel will explore the transformation imperative for life sciences and healthcare companies to adopt digitalization and advanced data science and analytical techniques in research, clinical development and care delivery. They’ll discuss best practices we see taking place thus far and the benefits they offer, as well as other ideas on key steps leaders can take to shift their particular business paradigm.

Neurology in particular is an area ripe for change where many diseases such as Alzheimer’s have been treatment stagnated. There has been an explosion of neuroimaging (brain) data with advances in radiological techniques and accessibility. That data, combined with ever more accessible clinical (EHR), genomic and real world data and its inherent complexity and volume make it ripe for the application of modern approaches in order to make strides in medicines to treat the vast disease areas it encompasses.

Organizations need to be able to evolve, integrate and communicate together effectively to take advantage of digital transformation. Come hear from our experts on their own case studies, or how they have helped others tackle these realities by putting in place actionable strategies for change.

Panelists

Kent

Kent Leslie
Global Head of R&D and CSO, Amylyx

Chris

Chris Llewellyn
Senior Partner, McKinsey & Company, Global Leader of Digital and Analytics for Life Sciences and Healthcare

Glenn

Glenn Thomas
CCO, QMENTA

WATCH ON DEMAND